Ascendis Pharma director HOLTUG LARS plans to sell 236 ordinary shares worth approximately $62,334.59. For investors, the stated purpose is to cover income tax, while the transaction record identifies the securities as compensation-linked holdings in a share plan account.

Key Highlights

  • The transaction uses an indicative Market Price of 264.1296.
  • The ordinary shares are held through a share plan account.
  • The securities are identified as compensation-related holdings.

Ascendis Pharma A/S (NASDAQ: ASND) director HOLTUG LARS filed a Form 144 to sell 236 ordinary shares valued at approximately $62,334.59. The filing lists 09/02/2026 and states that the sale is to cover income tax.

Share Plan Account and Compensation Classification

The transaction record classifies the holdings as compensation. Citigroup Global Markets is listed with an address at 390 Greenwich St, New York, NY 10,013. The indicative market price used in the record is 264.1296. The Acquisition dates for the securities are described as various. The sale concerns HOLTUG LARS, who is identified as a director of Ascendis Pharma A/S. The transaction record identifies the shares as compensation.